HeliTrax FAQ Contact Us Forward to a Friend

Hemophilia Patient Resources

HeliTrax^SM

Introducing the new HeliTrax^SM System—Bringing you and your HTC closer together

Electronic patient diary makes data entry easier for you
You can transmit data from anywhere with a true wireless, Internet-based device or web interface
The web interface provides a clear, clinical snapshot of your treatment—available in one report at any time to you and your HTC
Unique camera feature and high-priority alerts for rapid assessment of emergency bleeding events

More>>

www.HemophiliaMoms.com

If you have a child with hemophilia, check out www.HemophiliaMoms.com —the Web site with real stories from moms who are raising kids with hemophilia, combined with practical information to help parents meet day-to-day challenges. More>>

Gettin’ in the Game^SM

Gettin' in the Game was started by CSL Behring to encourage kids with bleeding disorders to be physically active. Children and their families get sports tips from professional athletes, participate in sports competitions, and meet other kids with bleeding disorders. More>>

Junior National Championships

Presented by National Hemophilia Foundation and CSL Behring, this fun-filled annual golf and baseball competition is for children ages 7 through 18. More>>

FactorPlus^SM - The Helixate^® FS Free Trial Program

With FactorPlus^SM - you can try an advanced recombinant factor VIII (rFVIII) treatment for Hemophilia A at no cost to you. When you sign up, you are eligible to receive 6 doses or up to 20,000 IU of Helixate^® FS. More>>

HTC/Chapter Locator

For families dealing with a bleeding disorder, the hemophilia treatment center (HTC) can be a tremendous source of support. Staffed with healthcare professionals who are expert in bleeding disorders, HTCs offer a wide range of patient education and support services. In addition, the National Hemophilia Foundation (NHF) has chapters at many of the HTCs. Find a treatment center/NHF chapter near you. More>>

Find a rep

Find a Helixate^® FS representative near you. More>>

Glossary

Definitions related to Helixate^® FS and hemophilia A More>>

For more information about programs and services offered by CSL Behring, call our Consumer Affairs Center at 1-888-508-6978.

Important Safety Information

Helixate^® FS, Antihemophilic Factor (Recombinant), is a recombinant factor VIII treatment indicated for the control and prevention of bleeding episodes and peri-operative management in adults and children (0-16 years) with hemophilia A. Helixate^® FS is also indicated for routine prophylaxis to reduce the frequency of bleeding episodes and the risk of joint damage in children with hemophilia A with no preexisting joint damage.

The most serious adverse reactions are systemic hypersensitivity reactions and the development of high-titer inhibitors necessitating alternative treatments to antihemophilic factor. The most common adverse reactions observed in clinical trials were inhibitor formation in previously untreated or minimally treated patients, skin-associated hypersensitivity reactions, infusion site reactions, and central venous access device (CVAD) line-associated infections.

Helixate^® FS is contraindicated in patients who have manifested life-threatening immediate hypersensitivity reactions, including anaphylaxis, to the product or its components, including mouse or hamster proteins.

Please see the full prescribing information.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.